BAP1 and renal cell adenocarcinoma: It has also been investigated that patients with mutations in certain genes, such as BRCA1 associated protein 1 (BAP1) and succinate dehydrogenase complex subunit B (SDHB), are also at a higher risk for developing RCC [13].